Correlation Between Pfizer and KIMCO

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and KIMCO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and KIMCO into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and KIMCO RLTY P, you can compare the effects of market volatilities on Pfizer and KIMCO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of KIMCO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and KIMCO.

Diversification Opportunities for Pfizer and KIMCO

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and KIMCO is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and KIMCO RLTY P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KIMCO RLTY P and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with KIMCO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KIMCO RLTY P has no effect on the direction of Pfizer i.e., Pfizer and KIMCO go up and down completely randomly.

Pair Corralation between Pfizer and KIMCO

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the KIMCO. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.63 times less risky than KIMCO. The stock trades about -0.05 of its potential returns per unit of risk. The KIMCO RLTY P is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  7,637  in KIMCO RLTY P on September 3, 2024 and sell it today you would earn a total of  62.00  from holding KIMCO RLTY P or generate 0.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy30.4%
ValuesDaily Returns

Pfizer Inc  vs.  KIMCO RLTY P

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
KIMCO RLTY P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days KIMCO RLTY P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for KIMCO RLTY P investors.

Pfizer and KIMCO Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and KIMCO

The main advantage of trading using opposite Pfizer and KIMCO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, KIMCO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KIMCO will offset losses from the drop in KIMCO's long position.
The idea behind Pfizer Inc and KIMCO RLTY P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum